OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
12
Results
Show all
Save search
Copy query
Show results for
Unknown
(12)
Release Date
2023
(4)
2022
(3)
2019
(2)
2024
(1)
2021
(1)
2011
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study.
Not available
S-EPMC8813209
|
biostudies-literature
Cite
COVID-19 vaccine-induced antibody and T-cell responses in immunosuppressed patients with inflammatory bowel disease after the third vaccine dose (VIP): a multicentre, prospective, case-control study.
Not available
S-EPMC9458592
|
biostudies-literature
Cite
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
Not available
S-EPMC10570718
|
biostudies-literature
Cite
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
Not available
S-EPMC9578965
|
biostudies-literature
Cite
An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations.
Not available
S-EPMC6858549
|
biostudies-literature
Cite
Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease.
Not available
S-EPMC6367005
|
biostudies-literature
Cite
A survey of the global impact of COVID-19 on the practice of pediatric anesthesia: A study from the pediatric anesthesia COVID-19 Collaborative Group.
Not available
S-EPMC8250770
|
biostudies-literature
Cite
A PSA SNP associates with cellular function and clinical outcome in men with prostate cancer.
Not available
S-EPMC11541583
|
biostudies-literature
Cite
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study.
Not available
S-EPMC9757903
|
biostudies-literature
Cite
Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3196382
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets